Biocat, Fundació BioRegió de Catalunya

2023

2024

Registration as it was on 09 Dec 2024

How to read and use this data card.
Download this datacard

Overview

Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.

Lobbying Costs

None declared

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

2.5 Fte (5)

Lobbyists with EP accreditation

High-level Commission meetings

Lobbying Costs over the years

Info

Biocat, Fundació BioRegió de Catalunya (Biocat)

EU Transparency Register

414525248490-97 First registered on 29 Dec 2022

Goals / Remit

Biocat is a strategic stakeholder and catalyst for building, promoting and projecting the Catalan life sciences and healthcare ecosystem, known as the BioRegion of Catalonia.
Biocat was established in 2006 as a public-private foundation at the behest of the Government of Catalonia and the Barcelona City Council to identify the needs of the BioRegion and implement a strategy and action plan to maximize the economic and social impact of life sciences and healthcare innovation in Catalonia.
Main focal points of Biocat’s strategy: Accelerating technology transfer and business growth by promoting activities to boost the sector’s capacities; Projecting the ecosystem, in order to position the BioRegion as one of the main healthcare innovation hubs in Europe; Fostering entrepreneurs and researchers’ innovative capacities and talent development; and Bringing together the ecosystem’s stakeholders with international players to generate synergies and opportunities for growth and scaling up.

Main EU files targeted

Biocat is mainly interested in the 4 political priorities of the EU, in particular those aimed at Developing a solid and dynamic economic base, Building a climate-neutral, ecological, fair and social Europe, and Promoting European interests and values in the world. Specifically, among the EC's stratgic priorities, Biocat is interested in the European Green Deal, the twin -sustainable and digital - transformation, resilience, technological sovereignty, and innovation with social impact.
It is also interested in initiatives related to the Recovery Plan for Europe.
Biocat is interested in EC actions in the following areas: Business and Industry (create a business-friendly environment, promote entrepreneurship, improve access to new markets, facilitate access to finance, provide access to information services and data on a free, full and open basis), Climate Action (Green Deal related to health industries), Digital Economy and Societies (Digital Europe Programme, Europe's Digital Decade), Research and Innovation (Horizon Europe), and Public Health (HERA, EMA, EHDS , EU4Health, Health-EU).

Address

Head Office

Baldiri Reixac 4Torre I (PCB)
Barcelona 08028
SPAIN

EU Office

Baldiri Reixac 4Torre I (PCB)
Barcelona 08028
SPAIN

Website

https://www.biocat.cat/en
People

Total lobbyists declared

5

Employment time Lobbyists

50% 5

Lobbyists (Full time equivalent)

2.5

Lobbyists with EP accreditation

No lobbyists with EP accreditations

Complementary Information

Robert Fabregat, CEO, is member of Critical Medicines Alliance
Montse Daban, Director of Strategic Foresight and International Relations, is president of CEBR, member of ECA's Board of Directors, and of the JICF of HERA
Other members of International relations team: Maria Cejas, Clara Mediñà and Núria Radó

Person in charge of EU relations

Data not provided by Register Secretariat due to GDPR

Person with legal responsibility

Data not provided by Register Secretariat due to GDPR
Categories

Category

Non-governmental organisations, platforms and networks and similar
Networking

Affiliation

- Council of European BioRegions
- EIT Health
- EEN (associated partner)
- ACCIO (Internationalization suport agent)
- Asebio
- ECHAlliance (advisory board for EU projects)

Member organisations

Biocat is the driving force behind the healthcare innovation ecosystem in Catalonia, working to scale and consolidate the life sciences and healthcare sector, generating social and economic impact, and positioning the BioRegion of Catalonia as an international benchmark. Established in 2006 at the initiative of the Government of Catalonia and the Barcelona City Council, Biocat is a public-private foundation with governance bodies comprising representatives from all stakeholders, both public and private.
The life sciences and health innovation ecosystem in Catalonia: more than 1,750 organizations that drive innovation in health and frontier research. The BioRegion has around a hundred research entities and over 1,400 companies, of which 550 are startups and scaleups.
Biocat does not have affiliated members or organisaitons, rather it works for the Regional Health Innovation Ecosystem, by mandate of the Government od Catalonia, the Barcelona City Council and the Trustees of the Board, comprising representatives of the industry, the academia, hospitals, research centers and public and private stakeholders, companies and patient organisations.
https://www.biocat.cat/en/about-biocat

Employment time	Lobbyists
50%	5

Financial Data

Interests represented

Does not represent commercial interests

Closed financial year

Jan 2023 - Dec 2023

Lobbying costs for closed financial year

Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.

Total organisational budget in closed year

2,579,628€

Major funding types in closed year

Grants, Public funding

Major contributions in closed year

Type	Name	Amount
Contribution	EIT Health	33,207€
Contribution	Government of Catalonia	1,234,125€
Grant	Bioman4R2, SMP	18,873€
Grant	BRIGHT, COSME (EISMEA)	75,433€
Grant	EATRIS Plus, Infradev	41,917€
Grant	EDAH, EIE	70,314€
Grant	INNAXE, EIE	37,129€
Grant	SafeNMedtech	17,450€
Grant	FLASH, HEU	8,168€

Other financial info